Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Mesothelioma
State:  California
Country:  U.S.A.
Results 1-12 of 12 for your search:
Start Over
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 3475-158, NCI-2015-02278, 163196, 2015-002067-41, NCT02628067
Nintedanib in Treating Patients with Malignant Pleural Mesothelioma That Is Recurrent or Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2015-010, NCI-2015-01412, 1506014121, NCT02568449
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: EZH-203, NCI-2016-01485, NCT02860286
18F-FSPG PET/CT in Finding Lesions in Patients with Advanced or Metastatic Cancer Receiving Therapy
Status: Active
Phase: Phase II
Type: Diagnostic
Age: 18 and over
Trial IDs: VARIMG0006, NCI-2015-01125, 31855, IRB 31855 / VARIMG0006, NCT02599194
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: EMR 100070-001, NCI-2013-02214, 2013-002834-19, NCT01772004
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CX-839-001, NCI-2014-01059, NCT02071862
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 18329, NCI-2016-01343, NCT02824042
GL-ONC1 with or without Eculizumab in Treating Patients with Solid Organ Cancers before Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GL-ONC1-011, NCI-2016-01782, NCT02714374
Accelerated Hypofractionated Radiation Therapy Immediately before Surgery in Treating Patients with Malignant Pleural Mesothelioma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-000487, NCI-2015-01736, JCCCID552, NCT02672033
Start Over